Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter

European Heart Journal

Volumn 24, Issue 13, 2003, Pages 1264-1272

  Reithmann, Christopher ^a   Dorwarth, U ^a   Dugas, M ^b   Hahnefeld, A ^a   Ramamurthy, S ^a   Remp, T ^a   Steinbeck, G ^a   Hoffmann, E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atrial fibrillation; Atrial flutter; Catheter ablation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; ARTICLE; CATHETER ABLATION; EYE DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTHYROIDISM; INFERIOR CAVA VEIN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SINUS BRADYCARDIA; SINUS RHYTHM; TRICUSPID VALVE;

ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS;

EID: 0038303292     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00233-1     Document Type: Article

References (17)

1. Huang DT, Monahan KM, Zimetbaum P et al. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:462-9.
2. Schumacher B, Jung W, Lewalter T et al. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999;83:710-3.
3. Nabar A, Rodriguez LM, Timmermanns C et al. Radio-frequency ablation of class 1C atrial flutter in patients with resistant atrial fibrillation. Am J Cardiol 1998;83:785-7.
4. Reithmann C, Hoffmann E, Spitzlberger G et al. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 2000;21:565-72.
5. Waldo AL. Transient entrainment of atrial flutter. In: Waldo AL, Touboul P, editors. Atrial Flutter, Advances in Mechanisms and Management. New York: Futura Publishing; 1996, p. 241-58.
6. Hoffmann E, Remp T, Gerth A et al. Does impedance monitoring during radiofrequency catheter ablation reduce the risk of impedance rise? Circulation 1993;88(Supply I):165.
7. Brugada P, Gürsoy S, Brugada J et al. Atrial flutter as a complication of antiarrhythmic drugs. In: Waldo AL, Touboul P, editors. Atrial flutter, Advances in Mechanisms and Management. New York: Futura Publishing; 1996, p. 353-62.
8. Kannel WB, Abbott RD, Savage DD et al. Epidemiologic features of atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
9. Furberg CD, Psaty BM, Manolio TA et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
10. Vaziri SM, Larson MG, Benjamin EJ et al. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation 1994;899:724-30.
11. Flaker GC, Fletcher KA, Rothbart RM et al. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation: Stroke Prevention In Atrial Fibrillation (SPAF) Investigators. Am J Cardiol 1995;76:355-8.
12. Paydak H, Kall JG, Burke MC et al. Atrial fibrillation after radiofrequency ablation of type I atrial flutter. Time to onset, determinants, and clinical course. Circulation 1998; 98:315-22.
13. Haissaguerre M, Shah DC, Jais P et al. Electrophysiologic breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;102:2463-5.
14. Oral H, Knight BP, Tada H et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-81.
15. Kanagaratnam L, Tomassoni G, Schweikert R et al. Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: Long-term follow-up. PACE 2001;24:1774-9.
16. Yu WC, Hsu TL, Tai CT et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2001; 12:887-92.
17. Gerstenfeld EP, Guerra P, Sparks PB et al. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001;12:900-8.